Correlation Between Veracyte and NextCure
Can any of the company-specific risk be diversified away by investing in both Veracyte and NextCure at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Veracyte and NextCure into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Veracyte and NextCure, you can compare the effects of market volatilities on Veracyte and NextCure and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Veracyte with a short position of NextCure. Check out your portfolio center. Please also check ongoing floating volatility patterns of Veracyte and NextCure.
Diversification Opportunities for Veracyte and NextCure
Excellent diversification
The 3 months correlation between Veracyte and NextCure is -0.65. Overlapping area represents the amount of risk that can be diversified away by holding Veracyte and NextCure in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NextCure and Veracyte is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Veracyte are associated (or correlated) with NextCure. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NextCure has no effect on the direction of Veracyte i.e., Veracyte and NextCure go up and down completely randomly.
Pair Corralation between Veracyte and NextCure
Given the investment horizon of 90 days Veracyte is expected to generate 0.7 times more return on investment than NextCure. However, Veracyte is 1.42 times less risky than NextCure. It trades about 0.27 of its potential returns per unit of risk. NextCure is currently generating about 0.06 per unit of risk. If you would invest 3,960 in Veracyte on November 1, 2024 and sell it today you would earn a total of 677.50 from holding Veracyte or generate 17.11% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Veracyte vs. NextCure
Performance |
| Timeline |
| Veracyte |
| NextCure |
Veracyte and NextCure Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Veracyte and NextCure
The main advantage of trading using opposite Veracyte and NextCure positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Veracyte position performs unexpectedly, NextCure can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NextCure will offset losses from the drop in NextCure's long position.| Veracyte vs. Crinetics Pharmaceuticals | Veracyte vs. Viridian Therapeutics | Veracyte vs. Cytokinetics | Veracyte vs. Structure Therapeutics American |
| NextCure vs. CytomX Therapeutics | NextCure vs. Spero Therapeutics | NextCure vs. Instil Bio | NextCure vs. Assembly Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Other Complementary Tools
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |